Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
The coagulation, fibrinolytic, anticoagulation, and complement systems are in delicate
balance with the vessel wall endothelium ensuring appropriate hemostasis. Coagulopathy …
balance with the vessel wall endothelium ensuring appropriate hemostasis. Coagulopathy …
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
I Valencia, J Lumpuy-Castillo, G Magalhaes… - Cardiovascular …, 2024 - Springer
Early since the onset of the COVID-19 pandemic, the medical and scientific community were
aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation …
aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation …
Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation
FC Ceballos, A Virseda-Berdices, S Resino… - Frontiers in …, 2022 - frontiersin.org
Background metabolic changes through SARS-CoV-2 infection has been reported but not
fully comprehended. This metabolic dysregulation affects multiple organs during COVID-19 …
fully comprehended. This metabolic dysregulation affects multiple organs during COVID-19 …
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study
E Corneo, R Garbelotto, G Prestes, CS Girardi… - Thrombosis …, 2023 - Springer
Background Because severe acute respiratory syndrome coronarivus 2 (SARS-CoV-2)
leads to severe conditions and thrombus formation, evaluation of the coagulation markers is …
leads to severe conditions and thrombus formation, evaluation of the coagulation markers is …
Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system
M Bailey, D Linden, H Guo-Parke, O Earley… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2 binds to ACE2 receptors, expressed within the lungs. Risk factors for
hospitalization include hypertension, diabetes, ischaemic heart disease and obesity …
hospitalization include hypertension, diabetes, ischaemic heart disease and obesity …
[HTML][HTML] Targeting thromboinflammation in COVID-19–A narrative review of the potential of C1 inhibitor to prevent disease progression
P Urwyler, S Moser, M Trendelenburg, P Sendi… - Molecular …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is associated with
a clinical spectrum ranging from asymptomatic carriers to critically ill patients with …
a clinical spectrum ranging from asymptomatic carriers to critically ill patients with …
The COMPASS-COVID-19-ICU study: Identification of factors to predict the risk of intubation and mortality in patients with severe COVID-19
GT Gerotziafas, P Van Dreden, DD Fraser, G Voiriot… - Hemato, 2022 - mdpi.com
In some patients, SARS-CoV-2 infection induces cytokine storm, hypercoagulability and
endothelial cell activation leading to worsening of COVID-19, intubation and death. Prompt …
endothelial cell activation leading to worsening of COVID-19, intubation and death. Prompt …